BridgeBio Pharma Inc (NASDAQ:BBIO)

39.63
Delayed Data
As of 3:59pm ET
 +0.06 / +0.15%
Today’s Change
14.23
Today|||52-Week Range
48.36
+13.07%
Year-to-Date
No recent news for BridgeBio Pharma Inc.

Today’s Trading

Previous close39.57
Today’s open40.70
Day’s range38.31 - 39.70
Volume28,913
Average volume (3 months)685,278
Market cap$4.8B
Data as of 3:59pm ET, 10/26/2020

Growth & Valuation

Earnings growth (last year)-111.73%
Earnings growth (this year)-38.49%
Earnings growth (next 5 years)-67.71%
Revenue growth (last year)--
P/E ratioNM
Price/Sales90.82
Price/Book11.98

Competitors

----
TEVATeva Pharmaceutical-0.22-2.35%
BGNEBeigene Ltd+1.37+0.46%
Data as of 4:00pm ET, 10/26/2020

Financials

Next reporting dateNovember 5, 2020
EPS forecast (this quarter)-$0.90
Annual revenue (last year)$40.6M
Annual profit (last year)-$260.6M
Net profit margin-642.47%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Palo Alto, California

Forecasts